The Anglo-Swedish pharmaceutical giant has been waiting to submit the approval of its vaccine for months, engaging in talks throughout the process.
Last April, the AstraZeneca chief said the drugmaker planned to file within a matter of weeks.
This is a breaking story. More to follow.
